Racing jurisdictions concentrated in the Mid-Atlantic and Northeast regions are finding progress to be a subjective term: Much has been accomplished, but much remains to be done.
A booklet put together by several individuals at the forefront of equine medication reform has been prepared for Maryland, which will enact the Mid-Atlantic Uniform Medication and Drug-Testing Program Jan. 1, 2014.
The Ohio State Racing Commission is moving forward to adopt drug-testing threshold levels as part of national model rules, and also indicated it will switch to post-race TCO2 screening and bring Thoroughbreds into the mix.
The Racing Medication and Testing Consortium has approved minimum withdrawal time recommendations for corticosteroids based on recently completed work partially funded by RMTC.
The Racing Medication and Testing Consortium board of directors has recommended withdrawal guidelines and plasma thresholds for a bronchodilator, a muscle relaxant, and four anabolic steroids.
- By Tom LaMarra
The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.
At least five Florida positives for a widely-used therapeutic tranquilizer have horsemen's groups on edge.
The Racing Medication and Testing Consortium board of directors Feb. 6 received an update on an anabolic steroids study, results of which will be used to set thresholds for testing in plasma.
The Maryland Racing Commission remains committed to regulating anabolic steroids in racehorses, but will delay implementation of a model rule given questions about the rule itself and laboratory testing procedures.
The model rule regulating use of anabolic steroids in racehorses is flawed and not based on scientific evidence, and the current state-by-state roll out of the regulations is problematic, horsemen's representatives said Jan. 25.
Racing officials Dec. 7 confirmed a push for regulation of anabolic steroids, and also said the therapeutic substances could be upgraded to Class 3 under Association of Racing Commissioners International guidelines by April 2007.
Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.
Most Popular Stories
- Retro Rebel: Smarty Jones Wowed in 2004
- What's Going On Here: Dude the Redeemer
- Louisiana Bills to Reduce Dates, Slots Money
- Jezki Wins Cheltenham's Champion Hurdle
- Gulfstream Uses Graded Stakes Testing Fund
- Dixiana to Sponsor Two Keeneland Stakes
- Slideshow: The Week in Photos for 3/11/2014
- Turfway to Boost Purses With KTDF Supplements
- Downey: Derby Trail, Where They're Going Next
- Steve Haskin's Derby Dozen 3/10/2014